Approvals/TGA/IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Approved

STANDARD

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Baxter Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: baebfccebd7f1146
Product Name: IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Artg Id: 246736
Artg Name: IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Sponsor: Baxter Healthcare Pty Ltd
Company Detail Path: /organization/baxter-healthcare-pty-ltd
Artg Date: 2016-05-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/44c62462725d180e11bc60d8390d6e4b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

baebfccebd7f1146

Type

Standard